Trial
NCT04189952
Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
AstraZeneca
Condition
Diffuse Large B Cell Lymphoma
Intervention
Acalabrutinib
Why stopped
Investigator Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-31